Also see: Expedia, Citigroup, Target: New RatingsEditor's Note: Green and red arrows refer to intraday stock price movement. NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES Alliance Data ( ADS) target boosted at RBC. Shares of ADS now seen reaching $96, according to RBC. Company should reach it's near-term earnings targets. Outperform rating. AmSurg Corp ( AMSG) price target boosted at Citi to $32.50 from $24. Bullish on acquisition of Dallas based National Surgical Care, Citigroup said. Maintain Buy rating. Constellation ( STZ) estimates, target upped at UBS. STZ estimates were boosted through 2013, UBS said. Company is realizing higher shipments. Buy rating and new $25 price target. Healthspring ( HS) estimates reduced at Goldman through 2013, Goldman Sachs said. Company is realizing a lower Medicare reimbursement. Neutral rating and $46 price target. Imax ( IMAX) target raised at Piper. Shares of IMAX now seen reaching $37. Company is expanding its reach across the globe. Overweight rating. JC Penney ( JCP) numbers upped at Piper. JCP estimates were boosted through 2012, Piper Jaffray said. Company is realizing higher sales. Neutral rating and new $32 price target. Limited Brands ( LTD) target boosted at Morgan Stanley. Shares of LTD now seen reaching $41, according to Morgan Stanley. Company is posting double-digit sales growth. Overweight rating. Priceline.com ( PCLN) estimates, target raised at Goldman. Shares of PCLN now seen reaching $600, according to Goldman Sachs. Estimates also increased, given expected growth in Europe. Buy rating. Pepsico ( PEP) estimates lowered at Goldman through 2012, Goldman Sachs said. Company is spending more on domestic marketing. Buy rating and $77 price target. Pfizer ( PFE) price target raised at Credit Suisse to $23 from $21. Value exists in the case of a Pfizer Animal Health spin-off, Credit Suisse said. Maintain Outperform rating. Pier 1 Imports ( PIR) price target higher at Credit Suisse. PIR shares now seen reaching $13, up from $11. Strong comps reinforce solid long-term growth, Credit Suisse said. Maintain Neutral rating. Seagate Technology ( STX) numbers increased at Goldman through 2013, Goldman Sachs said. Company is realizing higher margins. Neutral rating and new $16 price target. Target price target reduced at Goldman to $60, according to Goldman Sachs. Cinoany is seeing weaker sales. Buy rating.
Target price target cut at Credit Suisse to $54 from $58. Potential sale of TGT's credit card business and expenses related to its entry into Canada, Credit Suisse noted. Maintain Neutral rating. Tempur-Pedic ( TPX) estimates increased at Oppenheimer through 2012, Oppenheimer said. Company is seeing better sales across the board. Perform rating. Williams-Sonoma ( WSM) numbers raised at Oppenheimer to $51. Estimates also increased, as higher sales are driving better margins. Outperform rating. End of report.